The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma

✍ Scribed by Peled, A.; Abraham, M.; Avivi, I.; Rowe, J. M.; Beider, K.; Wald, H.; Tiomkin, L.; Ribakovsky, L.; Riback, Y.; Ramati, Y.; Aviel, S.; Galun, E.; Shaw, H. L.; Eizenberg, O.; Hardan, I.; Shimoni, A.; Nagler, A.

• Book ID: 121857009
• Publisher: American Association for Cancer Research
• Year: 2013
• Tongue: English
• Weight: 651 KB
• Volume: 20
• Category: Article
• ISSN: 1078-0432
• DOI: 10.1158/1078-0432.CCR-13-1302